ストックスクリーナーアプリを入手
9.07
1.31%
-0.12
前日終値:
$9.19
開ける：
$9.18
24時間の取引高:
1.03M
Relative Volume:
0.71
時価総額：
$1.23B
収益：
$175.51M
当期純損益:
$-78.02M
株価収益率:
-17.11
EPS:
-0.53
ネットキャッシュフロー:
$-34.18M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
+12.67%
6か月 パフォーマンス:
+13.38%
1年 パフォーマンス:
+63.13%
1日の値動き範囲:
$9.035
$9.36
1週間の範囲:
$8.55
$9.36
52週間の値動き範囲:
$5.195
$10.67
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
名前
Aurinia Pharmaceuticals Inc
セクター
電話
250-744-2487
住所
#140, 14315 - 118 AVENUE, EDMONTON, BC
AUPH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AUPH
Aurinia Pharmaceuticals Inc
|
9.07 | 1.20B | 175.51M | -78.02M | -34.18M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-11-04 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-05-05 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-12-10 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-10-28 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2021-01-25 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-11-03 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-17 | 開始されました | BTIG Research | Buy |
| 2020-05-05 | 開始されました | Cowen | Outperform |
| 2020-01-10 | 開始されました | Jefferies | Buy |
| 2019-12-16 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-03-16 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2018-02-08 | 開始されました | RBC Capital Mkts | Outperform |
| 2017-10-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-05-18 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-04-11 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-03-22 | 繰り返されました | FBR & Co. | Outperform |
| 2016-12-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-08-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-06-30 | 開始されました | H.C. Wainwright | Buy |
| 2015-05-08 | 開始されました | MLV & Co | Buy |
すべてを表示
Aurinia Pharmaceuticals Inc (AUPH) 最新ニュース
What analysts say about Aurinia Pharmaceuticals Inc. stockRapid growth opportunities - Autocar Professional
Is Aurinia Pharmaceuticals Inc. a good long term investmentTremendous financial leverage - Autocar Professional
Will Aurinia Pharmaceuticals Inc. stock split in the near futureHigh-octane financial growth - jammulinksnews.com
What drives Aurinia Pharmaceuticals Inc. stock priceUnmatched profit growth - Autocar Professional
When is the best time to buy Aurinia Pharmaceuticals Inc. stockSuperior profit margins - jammulinksnews.com
Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025 - BioSpace
Aurinia Pharmaceuticals to Announce Q2 2025 Financial Results - TipRanks
Aurinia Pharmaceuticals: LUPKYNIS Growth and AUR200 Pipeline Fuel Long-Term Value - AInvest
ISS Recommends That Aurinia Shareholders Vote "FOR" All Proposals at 2025 Annual General Meeting - Yahoo.co
Aurinia Pharmaceuticals Inc. Stock Analysis and ForecastBreakthrough investment results - jammulinksnews.com
(AUPH) Technical Data - news.stocktradersdaily.com
Aurinia Pharmaceuticals (NASDAQ:AUPH) Delivers Shareholders Favorable 52% Return Over 1 Year, Surging 5.5% in the Last Week Alone - 富途牛牛
Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics - Yahoo
What makes Aurinia Pharmaceuticals Inc. stock price move sharplyDaily Breakout Picks - Newser
How Aurinia Pharmaceuticals Inc. stock performs during market volatilityFree Stock Investment Discussion Area - Newser
Why Aurinia Pharmaceuticals Inc. stock attracts strong analyst attentionReal Trader Insights - Newser
How did AUPH's Q3 2024 earnings surprise impact short-term traders? - AInvest
Trading (AUPH) With Integrated Risk Controls - news.stocktradersdaily.com
Wheat from chaff in BAFF: APRIL’s advent for Aurinia? - BioWorld MedTech
The Play On Aurinia Pharmaceuticals: Rising Cash Flow Provides Opportunity (NASDAQ:AUPH) - Seeking Alpha
Retail Bulls Charge Into Aurinia Pharmaceuticals Ahead Of Autoimmune Trial Results - MSN
Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options - Nasdaq
Implied Volatility Surging For Aurinia Pharmaceuticals Stock Options - Barchart.com
Leerink Partners Keeps Their Buy Rating on Aurinia Pharmaceuticals (AUPH) - The Globe and Mail
Aurinia’s aritinercept shows promising results in phase 1 study - Investing.com
Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200) - New Castle News
(AUPH) Trading Report - news.stocktradersdaily.com
Aurinia Pharmaceuticals Inc (AUPH) 財務データ
収益
当期純利益
現金流量
EPS
3.32%
1.57%
大文字化:
|
ボリューム (24 時間):